Exact Sciences (EXAS) Net Income towards Common Stockholders: 2009-2025
Historic Net Income towards Common Stockholders for Exact Sciences (EXAS) over the last 17 years, with Sep 2025 value amounting to -$19.6 million.
- Exact Sciences' Net Income towards Common Stockholders rose 48.76% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$986.6 million, marking a year-over-year decrease of 360.86%. This contributed to the annual value of -$1.0 billion for FY2024, which is 403.97% down from last year.
- According to the latest figures from Q3 2025, Exact Sciences' Net Income towards Common Stockholders is -$19.6 million, which was down 1,553.50% from -$1.2 million recorded in Q2 2025.
- Exact Sciences' Net Income towards Common Stockholders' 5-year high stood at $794,000 during Q3 2023, with a 5-year trough of -$864.6 million in Q4 2024.
- In the last 3 years, Exact Sciences' Net Income towards Common Stockholders had a median value of -$49.8 million in 2023 and averaged -$123.2 million.
- Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first soared by 100.53% in 2023, then plummeted by 4,915.62% in 2024.
- Exact Sciences' Net Income towards Common Stockholders (Quarterly) stood at -$220.6 million in 2021, then spiked by 42.09% to -$127.8 million in 2022, then surged by 61.05% to -$49.8 million in 2023, then tumbled by 1,637.30% to -$864.6 million in 2024, then soared by 48.76% to -$19.6 million in 2025.
- Its Net Income towards Common Stockholders was -$19.6 million in Q3 2025, compared to -$1.2 million in Q2 2025 and -$101.2 million in Q1 2025.